Understanding the roles of glycosylated RNA species in homeostasis and human disease

Active Grant Awarded

Award ID
F32GM167207
Recipient
Awarding agency
Obligated
$76,300

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date 7% complete
Place of performance
Houston, TX 77005, USA

Award details come from USAspending.gov.

Description

Abstract
Abstract in 2021, flynn ET AL. Reported the existence of glycosylated rnas (GLYCORNAS), small RNA species decorated with glycans and localized on the surface of many mammalian cell types - a paradigm-challenging discovery which bridged the previously distinct scientific realms of RNA and glycoconjugates. Follow-up investigations into the nature of GLYCORNAS revealed that their expression is dynamically regulated, fluctuating during immune activation and cancer progression, demonstrating the importance of GLYCORNAS in human health and disease biology. However, the mechanistic determinants of these emerging glycorna functions remain elusive, in large part due to limitations of existing investigative techniques, which generally allow only blanket identification of glycorna species. We propose to leverage advances in AI-based protein design for the creation of DE novo protein binders as molecular tools for the precisely targeted investigation of GLYCORNAS and their interactions with native cellular machinery. We will first develop miniprotein binders against multiple epitopes of known endogenous glycorna-interacting proteins to identify critical interfaces for binding and cellular trafficking of GLYCORNAS. We will design ultraspecific DE novo glycorna binders based on our findings and employ them to investigate sequence- and glycan-specific interactions with cellular pathways. Finally, we will blockade protein- glycorna interactions in cellulo using our DE novo binders to investigate the roles of glycorna in homeostasis and disease progression with unprecedented specificity. By using these tools to investigate these mysterious biomolecules and their interactions with native cellular machinery, we will deepen the field's understanding of GLYCORNAS and uncover potential avenues for disease diagnosis, prevention, and treatment.

Transactions

Action Obligated Date
Amendment $0
Original award $76,300

Quick answers

Who received award F32GM167207?

F32GM167207 was awarded to William Marsh Rice University by National Institute of General Medical Sciences (National Institutes of Health) on September 9, 2026.

How much is award F32GM167207 worth?

$76,300 has been obligated on F32GM167207.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award